Table 2.
Baseline Laboratory results of study participants according to PWV quartiles.
| Pulse Wave Velocity, m/s | |||||
|---|---|---|---|---|---|
| Variables | Q1 (<6.3) | Q2 (6.3-7.4) | Q3 (7.5-8.8) | Q4 (>8.8) | P Value |
| Glucose (mg/dl) | 103.6±42.0 | 107.4±31.4 | 116.5±55.8 | 122.2±55.2 | <0.001 |
| BUN (mg/dl) | 26.0±8.7 | 29.4±9.1 | 31.8±11.0 | 36.2±14.6 | <0.001 |
| Creatinine (mg/dl) | 0.83±0.2 | 0.88±0.37 | 0.91±0.32 | 0.96±0.34 | <0.001 |
| Creatinine clearance (ml/min) | 98.9±19.8 | 86.2±16.9 | 80.5±16.4 | 72.4±19.1 | <0.001 |
| UAE n (%) | 21.3% | 18.1% | 19.4% | 41.2% | <0.001 |
| Uric acid (mg/dl) | 4.8±1.4 | 5.1±2.0 | 5.1±1.3 | 5.5±1.6 | <0.001 |
| AST | 22.3±15.7 | 22.7±10.1 | 22.8±12.0 | 22.3±10.2 | 0.6 |
| ALT | 22.4±16.1 | 23.2±15.2 | 23.3±15.2 | 20.1±14.2 | 0.1 |
| Total bilirubin | 0.55±0.29 | 0.56±0.29 | 0.60±0.31 | 0.58±0.31 | 0.1 |
| HBG (mg/dl) | 13.8±1.5 | 13.7±1.6 | 13.8±1.5 | 13.5±1.5 | 0.2 |
| HTC (%) | 41.9±4.5 | 41.6±4.6 | 41.9±4.4 | 41.3±4.4 | 0.5 |
| WBC (K/ul) | 8.1±2.3 | 7.9±2.2 | 7.7±2.2 | 7.8±2.2 | 0.01 |
| Neutrophils (mm3 ) | 5.0±2.0 | 4.9±1.8 | 4.6±1.7 | 4.8±1.8 | <0.001 |
| Lymphocytes (mm3 | 2.3±0.7 | 2.2±0.6 | 2.2±0.7 | 2.1±0.7 | 0.03 |
| PLATELET (×103 /L) | 271.9±70.3 | 276.7±65.0 | 266.9±66.9 | 250.1±65.5 | <0.001 |
| MPV (fL) | 9.1±1.3 | 9.2±1.3 | 9.0±1.2 | 9.2±1.3 | 0.07 |